Skip to main content
Shaping Europe’s digital future
Factsheet / infographic | Publication

Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing (MAFEIP)

This infographic provides an over view of the Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing, the tool that measures cost effectiveness and makes impact assessments of ICT health and care solutions. It highlights who can benefit from MAFEIP, how you can get assistance, and includes two success stories from digital solutions that applied MAFEIP.

This infographic provides an over view of the Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing, the tool that measures cost effectiveness and makes impact assessments of ICT health and care solutions.

Text description

MAFEIP

Measures cost effectiveness and makes impact assessments of ICT health and care solutions. A web-based tool that bases its calculations on a Markov Model. It compares patients at two time-instants.

Monitoring and Assessment Framework for the European Innovation Partnership on Active and Healthy Ageing

Who can benefit from MAFEIP?
Health or Social Care Providers | Project Managers | Researchers | Policymakers 

Do you need help?
A MAFEIP team of experts provides support through the whole process

Success Stories: Digital Solutions that Applied MAFEIP

i-Prognosis

An app that measures the use of games by people with Parkinson’s.

Result: cost-effective 

The adoption of the app could save 400-550 euros per patient
a year in healthcare costs. Expected decrease in healthcare costs over a horizon of 20 years:

• 8 million euros in Greece

• 72 million euros in Germany 

• 98 million euros in the United Kingdom

CareWell  

A project that measures the care of frail, elderly patients.

Result: cost-effective

• The intervention is effective if there is a willingness to pay that
   is at least €5,667 per quality-adjusted life year for each patient

• The intervention is more effective than current care

• The intervention is also more expensive than current care

Author

WE4AHA Coordination and Support Action (CSA) 2017-2020